share_log

Ladenburg Thalmann Upgrades Aileron Therapeutics to Buy, Announces $9 Price Target

Benzinga ·  Dec 2, 2023 00:43

Ladenburg Thalmann analyst Aydin Huseynov upgrades Aileron Therapeutics (NASDAQ:ALRN) from Neutral to Buy and announces $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment